Furthermore, with the aid of transcriptomic analysis and ChIP-qRT-PCR assay, we identified that RUNX2/MMP1 axis functioned a crucial role in the malignant progression and poor prognosis in triple negative breast cancer (Figure 10). Here, MMP1 is linked to triple-negative breast carcinoma.